Details of the Drug

General Information of Drug (ID: DMSZ849)

• Drug Name: HS-10296

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Phase 1/2	[1]

• Cross-matching ID:
  PubChem CID: 121280087
  TTD ID: D0J6WA

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)